BusinessAdmin•Yahoo Finance RSS•a day ago
Eli Lilly Pursues $7 Billion Acquisition of Kelonia, Offering $3.25 Billion Upfront
Eli Lilly is set to acquire Kelonia for $7 billion, with $3.25 billion paid upfront, inviting early investor participation.
- • Eli Lilly is planning a significant acquisition of Kelonia, valued at $7 billion, with an initial payment of $3.25 billion.
- • This deal positions Eli Lilly to enhance its portfolio and expand its market presence, particularly in innovative therapies.
- • Investors are being encouraged to consider early involvement in the deal, which may offer potential financial benefits as the acquisition progresses.
Source: Yahoo Finance RSS
Read original →
